ALPS Advisors’s Acadia Healthcare ACHC Stock Holding History

ALPS Advisors’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-8,172	Closed	-$270K	–	730
2016 Q4	$270K	Buy	8,172 +77	+1%	+$2.99K	﹤0.01%	679
2016 Q3	$401K	Buy	+8,095	New	+$422K	﹤0.01%	603

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ALPS Advisors's ACHC Position: Q1 2017 in Review

ALPS Advisors sold out of Acadia Healthcare (ACHC) in Q1 2017, closing a stake of 8,172 shares — an estimated $270K sold.

ALPS Advisors first reported a position in ACHC in Q3 2016 and held it in 2 quarters. The position peaked at $401K in Q3 2016. 233 funds tracked by Wall St. Rank hold ACHC as of Q1 2017.

ALPS Advisors reported no remaining Acadia Healthcare position as of Q1 2017 after selling out during the quarter.
ALPS Advisors sold 8,172 Acadia Healthcare shares in Q1 2017, an estimated $270K.
ALPS Advisors first reported a position in Acadia Healthcare in Q3 2016 and held it in 2 quarters.
ALPS Advisors's Acadia Healthcare position peaked at $401K in Q3 2016.
233 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2017.

Based on ALPS Advisors's 13F filing for Q1 2017, filed 12 May 2017.